Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ambroxol inhalation solution for mucus symptoms in pediatric lower respiratory tract infection
CTR20160951Phase 3Active
- Sponsor
- Jilin Sihuan Pharmaceutical
- Start
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ambroxol in pulmonary infection, acute bronchitis, pneumonia, sponsored by Jilin Sihuan Pharmaceutical. Started Dec 2016; status: active.
02
Drugs
ambroxol
03
Conditions
pulmonary infectionacute bronchitispneumonia
Beyond the preview
Go deeper on CTR20160951.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20160951.